Clinical Trial Update: Phase II Trial of Lapatinib & Capecitabine for Patients With Refractory Advanced Colorectal Adenocarcinoma [Phase 2]

View source ↗

Summary

Phase II trial investigating lapatinib in combination with capecitabine for refractory advanced colorectal adenocarcinoma has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Capecitabine (capecitabine)
• Lapatinib (Lapatinib)

Snippet

Sponsor: University of Wisconsin, Madison | Conditions: Metastatic Colorectal Cancer | Phase 2 | Status: COMPLETED | Results posted: 2015-07-14